HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Steroid bills

This article was originally published in The Tan Sheet

Executive Summary

House Government Reform Committee Chairman Tom Davis (R-Va.) will introduce a bill the week of May 23 proposing a uniform drug testing policy for major professional sports leagues, including MLB, the NFL and the NBA. Co-authored by Rep. Henry Waxman (D-Calif.) and Sen. John McCain (R-Ariz.), the legislation likely will suggest similar penalties to Rep. Cliff Stearns' (R-Fla.) Drug Free Sports Act, which calls for minimum two-year bans for first offenses and lifetime bans for second offenses. The House Government Reform Committee held a hearing on the NBA's drug policy on the heels of an NFL meeting in April (1"The Tan Sheet" May 2, 2005, p. 14)...

You may also be interested in...

NFL Supplement Policy Not Hindered By Lack Of GMPs – Tagliabue

The absence of dietary supplement good manufacturing practices has had minimal impact on the National Football League's steroid policy, according to Commissioner Paul Tagliabue

Formycon Chief Sees COVID-19 Boosting Biosimilars

Formycon’s CEO has offered the latest indication that the coronavirus outbreak could provide a tailwind for biosimilars, as the firm gave an update on its biosimilars pipeline – including ranibizumab, ustekinumab, aflibercept and an undisclosed molecule, as well as other unrevealed projects – and how it has been affected by the pandemic.

PDUFA Renewal Negotiations: What Does Industry Want Now?

With the formal, virtual kick-off meeting set for 23 July, US FDA and sponsors are looking at a transformed landscape as they discuss what the next five years of user fees will look like.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts